Intermolecular
IMI
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-17.3945
2.336
2.140
59,461,077.68
News
Financial
Releases
Corp Actions
Analysis
Profile
Could Be 15 Months Before We Have Vaccine: Merck KGaA CFO
bloomberg.com · 08/06 08:24
No Data
Learn about the latest financial forecast of IMI. Analyze the recent business situations of Intermolecular through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IMI stock price target is 1.200 with a high estimate of 1.200 and a low estimate of 1.200.
EPS
Institutional Holdings
Institutions: 41
Institutional Holdings: 30.43M
% Owned: 61.15%
Shares Outstanding: 49.76M
TypeInstitutionsShares
Increased
3
614.20K
New
20
11.14M
Decreased
5
1.16M
Sold Out
8
3.26M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Semiconductors
+0.94%
Semiconductors & Semiconductor Equipment
+0.98%
Key Executives
Chairman/Director
Kenneth Traub
Chief Financial Officer/Chief Accounting Officer
Bill Roeschlein
Independent Director
Marvin Burkett
Independent Director
Irwin Federman
Independent Director
Matthew Furnas
Independent Director
Christian Kramer
Independent Director
George Scalise
Independent Director
Adam Scheer
Independent Director
Jonathan Schultz
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Intermolecular stock information, including NASDAQ:IMI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IMI stock methods without spending real money on the virtual paper trading platform.